<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li N</submitter><funding>American Heart Association</funding><funding>American Heart Association-American Stroke Association</funding><funding>South Dakota Board of Regents</funding><pagination>61-69</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11264340</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>93</volume><pubmed_abstract>Construction of an artificial vascular graft is widely considered a promising strategy in vascular tissue engineering. However, limited sources of functional vascular smooth muscle cells (VSMCs) remain a major obstacle in vascular tissue engineering. In this study, we innovatively developed an approach to obtain functional VSMCs by onsite differentiating human bone marrow-derived mesenchymal stem cells (MSCs) directed by decellularized extracellular matrix (ECM) and fibroblasts. The resulting cells and ECM-cells constructs were characterized by real time RT-PCR, immunofluorescence staining, cell contractile functions, and migration capacity. Our results showed both ECM and fibroblasts induced MSCs differentiation toward VSMC-like cells with increased transcription of marker genes, upregula</pubmed_abstract><journal>Materials science &amp; engineering. C, Materials for biological applications</journal><pubmed_title>Vascular extracellular matrix and fibroblasts-coculture directed differentiation of human mesenchymal stem cells toward smooth muscle-like cells for vascular tissue engineering.</pubmed_title><pmcid>PMC11264340</pmcid><funding_grant_id>15SDG25420001</funding_grant_id><funding_grant_id>UP1600205</funding_grant_id><pubmed_authors>Hong Z</pubmed_authors><pubmed_authors>Sanyour H</pubmed_authors><pubmed_authors>Kelly P</pubmed_authors><pubmed_authors>Li N</pubmed_authors><pubmed_authors>Remund T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vascular extracellular matrix and fibroblasts-coculture directed differentiation of human mesenchymal stem cells toward smooth muscle-like cells for vascular tissue engineering.</name><description>Construction of an artificial vascular graft is widely considered a promising strategy in vascular tissue engineering. However, limited sources of functional vascular smooth muscle cells (VSMCs) remain a major obstacle in vascular tissue engineering. In this study, we innovatively developed an approach to obtain functional VSMCs by onsite differentiating human bone marrow-derived mesenchymal stem cells (MSCs) directed by decellularized extracellular matrix (ECM) and fibroblasts. The resulting cells and ECM-cells constructs were characterized by real time RT-PCR, immunofluorescence staining, cell contractile functions, and migration capacity. Our results showed both ECM and fibroblasts induced MSCs differentiation toward VSMC-like cells with increased transcription of marker genes, upregula</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Dec</publication><modification>2025-05-18T13:26:43.826Z</modification><creation>2025-05-18T13:26:43.826Z</creation></dates><accession>S-EPMC11264340</accession><cross_references><pubmed>30274093</pubmed><doi>10.1016/j.msec.2018.07.061</doi></cross_references></HashMap>